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ABSTRACT 
Background 
Concerns have been raised about variation in care quality and outcomes among children and young 
people with epilepsies in England. We aimed to investigate the relationship between quality of 
paediatric care, hospital admissions and epilepsy-related deaths (both before and after transition to 
adult services).  
Methods 
We accessed unit-level data from Round 1 (2009-11) and Round 2 (2013-14) of the Epilepsy12 
national clinical audit, and data on death registrations and unplanned hospital admissions. We 
investigated the association between unit-level performance in involving a paediatrician with epilepsy 
expertise, Epilepsy Specialist Nurse (ESN), and Paediatric Neurologist (PN) in Round 1 and the 
proportion of adolescents with epilepsy admitted to each unit who subsequently died during the study 
period (2009-15). We also investigated whether change in Epilepsy12 performance between the audit 
rounds was associated with change in the standardised ratio of observed:expected unplanned epilepsy 
admissions. 
Findings 
79/1164(7%) of patients included in the PN analyses died; 54/1164(5%) deaths occurred post-
transition. Regression models estimated an absolute reduction of 6%(95% CI 1-13%) in total mortality 
risk and 6%(1-11%) post-transition mortality risk between units where all versus no eligible patients 
were seen by a PN. In dichotomised analyses, units where all eligible patients were seen by a PN were 
estimated to have 5%(0-9%) absolute mortality reduction and 5%(1-8%) reduction in post transition 
deaths compared to other units. There was no significant association between performance on other 
audit measures and mortality. In units where access to an ESN deteriorated, the standardised ratio of 
epilepsy admissions increased by a mean of 0·21 (95% CI 0·01-0·42). 
Interpretation 
Among adolescents with epilepsy, greater involvement of tertiary specialists in paediatric care predicts 
lower mortality in the period after transition to adult services. Reduced access to an ESN was 
associated with an increase in paediatric epilepsy admissions. 
Funding 
The Health Foundation (#7383). 
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RESEARCH IN CONTEXT PANEL 
 
Evidence before this study 
We did not perform a new literature search as the National Institute for Health, Care & Excellence 
(NICE) has published several comprehensive reviews of the evidence on delivering paediatric epilepsy 
care, including guidance in 2004 and 2012, an evidence update in 2014, and a surveillance report in 
2018. High quality evidence is available to guide choice of anti-epilepsy drug for many types of 
epilepsy, and appropriate choice of drug is known to reduce mortality risk. In contrast, NICE 
recommendations regarding the organisation and delivery of paediatric epilepsy services have always 
been based on Level C evidence (expert opinion), indicating that 'directly applicable clinical studies of 
good quality are absent or not readily available'.  
 
Added value of this study 
By linking national datasets from the Epilepsy12 national clinical audit, Hospital Episode Statistics, 
and the Office of National Statistics, we performed a novel investigation into the links between quality 
of paediatric epilepsy care and two key outcomes: all-cause mortality among adolescents with epilepsy 
and rates of hospital admission for paediatric epilepsy. We found that 7% of adolescents with epilepsy 
who were admitted to hospital died within the study period (median 4.5 years, range 3.0-6.0 years). 
Adolescents who were managed within paediatric units that met national guidelines on involving 
paediatric neurologists were less than half as likely to die in the period following transition to adult 
services compared to patients who were managed in other units. In absolute terms, fully meeting 
guidelines for involving paediatric neurologists was associated with 5 (95% CI 1-8·) fewer deaths per 
hundred patients. Units where involvement of an Epilepsy Specialist Nurse (ESN) deteriorated over 
time experienced a significant increase in standardised epilepsy admissions over the same period.  
 
Implications of all the available evidence 
While improving the organisation and delivery of local paediatric epilepsy services will continue to be 
important, our findings suggest that increasing capacity and involvement of paediatric neurologists 
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could be an effective strategy to reduce epilepsy-related mortality among young people in England, 
which is high by international standards, and is known to include many potentially avoidable deaths.  
While our findings cannot be directly applied to other countries with different health systems, the 
principle that high quality paediatric care can reduce epilepsy-related mortality is highly relevant 
globally. Our finding that higher quality healthcare in early/mid adolescence predicts lower mortality in 
early adulthood deserves further investigation, and may have important wider implications for the care 
of other long-term conditions, 
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INTRODUCTION 
 
Epilepsy is estimated to affect over 112,000 children and young people (CYP, 0-24 years), in the UK 
alone.(1) Quality and coordination of health care are important determinants of outcomes for CYP with 
epilepsy(2-6); failure to provide consistently high-quality care for CYP with epilepsies has been linked 
to high rates of over- and under-diagnosis of epilepsy,(1, 7)  wide geographical variation in epilepsy 
admission rates and deaths(8, 9)  the presence of avoidable factors in epilepsy-related deaths (4, 10) 
and higher mortality rates from epilepsy among young people in the UK than comparable 
countries.(11) Particular concerns have been raised that fragmented or poor quality services often do 
not meet the needs of adolescents with epilepsy during their transition to adult life, further exacerbating 
risk among a group who are already at increased risk of death from Sudden Unexpected Death in 
Epilepsy (SUDEP), injuries, suicide and other causes.(1-3)  
 
In response, national policy initiatives over more than a decade have focussed on defining, facilitating, 
and incentivising high quality care for CYP with epilepsy, through NICE guidance(12), training,(13) 
regional networks,(14) the Epilepsy12 national clinical audit,(6)  and the Best Practice Tariff (BPT) for 
paediatric epilepsy.(15) However, the diverse nature of the epilepsies presents challenges in validating 
standardised, evidence-based quality measures. Despite international endorsement and widespread 
adoption in NHS policies, the performance measures included in NICE guidance and the Epilepsy12 
audit are largely based on expert consensus,(12) with little empirical evidence that improving 
performance on these measures would reliably reduce mortality or hospital admission, or improve other 
patient-important outcomes.  
 
The aim of this study is to investigate the relationship between unit performance in three key measures 
of the Epilepsy12 national clinical audit(6) (involvement of a paediatrician with expertise in epilepsy, 
an Epilepsy Specialist Nurse (ESN) and, where appropriate, a Paediatric Neurologist (PN)), and two 
outcome measures that are believed to be both important and sensitive to the quality of paediatric care: 
• the proportion of adolescents (10-18 years) admitted to hospital with epilepsy who 
subsequently died within the study period. For the reasons noted above, we were particularly 
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interested in the relationship between quality of paediatric care and deaths pre/post transition 
to adult services.  
• rates of unplanned epilepsy-related hospital admissions (0-18 years) 
We hypothesised that patients managed in units that performed better in some or all of these three 
measures would have lower risk of mortality and unplanned hospital admissions.  
 
METHODS 
Study design and participants 
We first created a dataset with linked, unit-level data on Epilepsy12 performance (Round 1), hospital 
admissions and death registrations. Data from Round 1 of the Epilepsy 12 national clinical audit were 
obtained from the Royal College of Paediatrics & Child Health (RCPCH).(6) All paediatric epilepsy 
services in England were invited to take part in this audit of consecutive new patients who met 
inclusion criteria (see Table 1). Case notes were reviewed retrospectively for a 12-month period of care 
prior to the census data in each Trust (either 1st February or 1st May 2011).  
 
We linked unit (clinical service) identifiers within the Epilepsy12 audit to HES Trust identifiers, 
excluding all units where consistent, one-to-one linkage throughout the study period was not possible. 
Differences in case mix prevented direct comparison of admission and mortality rates between tertiary 
and secondary care services; tertiary centres (defined as any Trust employing a Paediatric Neurologist) 
were therefore excluded from these analyses. Units with fewer than two eligible patients for a given 
indicator were also excluded. See Figure 1 for full details of the linking process and exclusions.  
 
Ethics: A dataset combining Hospital Episode Statistics (HES) data(16) and death registrations from 
the Office for National Statistics (ONS)(17) was approved for the purpose of these analyses and 
provided by the Health and Social Care Information Centre (HSCIC).  
 
Independent/exposure variables (from Epilepsy12 audit data) 
The 3 performance measures were the proportions of patients in each unit who, within the 12-month 
period following their first assessment, were seen by a 
• Paediatrician with expertise in epilepsy  
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• Epilepsy Specialist Nurse (ESN)  
• Paediatric Neurologist (PN) (where appropriate - see Table 1 for eligibility criteria) 
 
For the grouped analyses, we allocated units to one of three categories for each performance measure: 
• Good performance (100% of patients received the recommended standard of care) 
• Moderate performance (50-99%) 
• Poor performance (0-49%) 
 
Dependent/outcome variables (from hospital/death registration data) 
The primary outcome measure was the proportion of adolescents admitted to participating units with 
epilepsy who subsequently died within the study period (1st April 2009 – 31st March 2015). Due to 
long-standing concerns about increased mortality risk following transition from paediatric to adult 
services, we then disaggregated deaths into those that occurred pre- and post transition. Deaths were 
defined as post-transition if they occurred after the first planned adult appointment or more than 6 
months after their last planned paediatric appointment. 
 
In order to study this outcome measure, we used HES data to identify a cohort of adolescent epilepsy 
patients who met three criteria: 
- one or more inpatient admissions for epilepsy (ICD10 codes G40, G41) during the period 
1st April 2004 to 31st March 2012 
- age between 10 and 18 years at the time of first admission 
- last planned paediatric appointment occurred between April 1st, 2009 and March 31st, 
2012. 
 Data linkage to ONS mortality data then identified which members of this cohort died within the study 
period (1st April 2009 – 31st March 2015). 
 
Admissions measures  
The second set of analyses used longitudinal, linked analyses of prospectively collected data to 
investigate the association between Epilepsy12 performance and standardised ratios of 
observed:expected epilepsy admissions in each unit. We examined whether change in unit-level 
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performance between Rounds 1 & 2 of Epilepsy12 was associated with a change in standardised 
admission ratios over the same period. 
 
We created a dataset with linked data from the two rounds of Epilepsy12 (census dates 1st February/1st 
May 2011 and 1st January 2014), HES data (2011/12 and 2013/14) and ONS data on population size 
and socio-economic deprivation. The ONS data were used to derive the denominator of unit-level 
admission rates (i.e. the hospital catchment population).(18) In addition to the exclusion criteria 
described above, units were also excluded if their reporting structure for Epilepsy12 changed between 
the two audit rounds (for example, if they submitted jointly with another unit in one round). See Figure 
1 for details.  
 
Independent/exposure variables (from Epilepsy12 audit data) 
The same three Epilepsy12 performance measures were used as for the mortality analyses: proportion 
of patients with involvement of a paediatrician with expertise in epilepsy, Epilepsy Specialist Nurse 
(ESN), Paediatric Neurologist (PN) (where appropriate). Units were stratified into three groups for 
each performance measure based on whether the proportion of patients receiving recommended care in 
2013-14 was better, exactly the same, or worse than in 2009-11 
 
Dependent/outcome variables (derived from hospital data) 
Changes in unit-level admissions were assessed by comparing the ratio of observed:expected 
unplanned epilepsy admissions for patients 0-18 years (ICD10 codes for primary reason for admission 
= G40, G41) in 2011/12 and 2013/14. Expected values were derived from the national admission rate, 
adjusted for the size, age distribution and socio-economic deprivation of the population served by each 
hospital, using methods that we have published previously.(19) 
 
Statistical Analyses  
Mortality analyses 
Longitudinal analyses of prospectively-collected, linked data were performed. For each Epilepsy12 
performance measure, the total number of patients and deaths in good/moderate/poor performing units 
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were calculated and compared using Fisher’s exact test. These analyses were then repeated separately 
for pre-transition and post-transition deaths.  
 
Next, the association between performance on PN involvement and unit-level mortality (total and post-
transition) was calculated using Spearman’s Rho (non-parametric test) and unadjusted, ordinary-least-
squares, linear regression models (in which unit-level performance was the independent, continuous 
variable and proportion of patients who died was the dependent variable). To address confounding, 
subsequent regression models adjusted for population characteristics (Mean Index of Multiple 
Deprivation (IMD) quintile (an area-based measure of socio-economic position),  
Ethnicity (defined as proportion of patients who were White, Mixed ethnicity, Asian, Black, Other 
ethnicity)) and unit characteristics  (Number of patients, Mean transition age, Does the unit host a 
paediatric neurology clinic*, Does the unit have a young people clinic*, Is there an adult Epilepsy 
Specialist Nurse*), as well as healthcare activity (the best available proxy measure for disease 
severity). Healthcare activity was separated into pre-transition activity (Mean number of inpatient care 
episodes, Mean number of outpatient visits, Mean number of contacts with mental health services, 
Mean number of unplanned care episodes) and hospital activity post-transition (Mean number of 
inpatient care episodes, Mean number of contacts with mental health services, Mean number of 
unplanned care episodes). Attendance at adult outpatient clinics is known to reflect the quality of 
preparation for transition and to predict mortality risk (27); a separate model was therefore used in 
which covariates reflecting attendance and engagement with adult outpatient services (Proportion of 
patients with any adult outpatient visits, Proportion of patients with adult outpatient visit within 12 
months of last paediatric appointment,  Proportion of patients with adult outpatient visit within 6 
months of last paediatric appointment, Proportion of patients with adult outpatient visit within 6 
months of last paediatric appointment and at least two further visits within next 24 months) were 
included in addition to the other variables listed above. Variables marked with an asterisk were binary 
variables; all others were continuous variables.  
 
Finally, these regression models were repeated, entering unit performance as a dichotomised (100% vs. 
<100% patients received recommended care) rather than a continuous variable. All models were 
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weighted for size of unit (number of paediatricians). P values <0.05 were considered significant 
throughout.  
 
Admissions Analyses 
The mean changes in observed:expected admission ratio for units reporting better/same/worse 
performance on each measure were calculated, as were the range and distributions of change in 
performance in each group. 
 
Statistical software 
All linkage analyses were performed using Stata version 14 (Stata Corp, College Station, TX). 
Calculation of observed:expected admission ratios was performed using SAS Version 9.3 (SAS 
Institute Inc, NC).  
 
Role of the funding source 
The Health Foundation had no role in study design; in the collection, analysis, and 
interpretation of data; in the writing of the report; and in the decision to submit the paper for 
publication. 
 
RESULTS 
 
Mortality analyses 
Linked mortality data were available for the analyses relating to paediatricians with epilepsy expertise 
and ESNs from 99 units. A total of 134/1795 (7%) patients from these units died during the study 
period; 46 (3%) died pre-transition and 88 (5%) died post-transition. In the smaller group of 55 units 
used for analysis of PN involvement, 79/1164 (7%) of patients died; 25 (2%) died pre-transition and 54 
(5%) post-transition. 
 
There was an inverse correlation between unit-level performance on involving a paediatric neurologist 
and the proportion of patients who died (Spearman’s Rho=-0·2767, p=0·041). This association was 
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more significant when restricting to post-transition deaths (Spearman’s Rho=-0·3256, p=0·015). No 
other significant associations were seen.  
 
Regression analyses that adjusted for population, unit and severity characteristics estimated an absolute 
reduction of 6% (95% CI 1-13%, p=0·046) in total mortality risk and 6% (1-11%, p=0·028) post-
transition mortality risk between units where all versus no eligible patients were seen by a PN (see 
Table 2a and Appendix Figure 1).  
 
Moving to the grouped analyses, Table 3 shows the proportion of epilepsy patients who died by unit 
performance on Epilepsy12 measures. Patients admitted to units where all eligible patients saw a PN 
were less likely to die during the follow up period (10/231=4%) than their counterparts in other units 
(69/933=7%). This difference reflected a lower number of post-transition deaths (5/231=2% vs. 
49/933=5%), which was of borderline statistical significance (p=0·053 (two-tailed), p=0·027 (one-
tailed)). No significant difference was seen for pre-transition deaths (5/231=2% vs. 20/933=2%), and 
no significant associations were seen between performance on other audit measures and mortality. 
 
Dichotomised regression analyses showed that units where all eligible patients were seen by a PN had 
an estimated 5% (0-9%, p=0.038) fewer total deaths and 5% (1-8%, p=0.010) fewer post transition 
deaths than other units where no or some eligible patients were seen.  Units where all eligible patients 
saw a PN were less likely to report access to an adult Epilepsy Specialist Nurse (6/12 (50%) vs. 39/43 
(91%), p=0·004) and marginally less likely to report having a dedicated young people’s clinic (0/12 vs. 
12/31 (28%), p=0·050). These units also reported higher levels of planned care after transition (a 
marker for access to, and engagement with, specialist adult neurology services). A significantly higher 
proportion of patients from these units attended an adult epilepsy clinic within 6 months (57 vs. 40%, 
p=0·011), within 12 months (69 vs. 55%, p=0·015), or at any time within the study follow up period 
(89 vs. 77%, p=0·006) and a higher proportion of patients met criteria for successful transition (defined 
as attending an adult clinic within 6 months of the last paediatric appointment and then attended at least 
two further appointments within the subsequent 2 years) (46 vs. 33%, p=0·019).There were no 
significant differences in other characteristics (see Appendix Table A).  
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Admissions analyses 
Data for unplanned admissions analyses relating to paediatricians with expertise and ESNs were 
available on 74 units, which accounted for 4,436 epilepsy admissions and served an estimated 
population of 5·68 million CYP in 2011/12 (4,079 admissions and 5·71 million population in 2013/14). 
The equivalent figures for analyses relating to Paediatric Neurologists were 25 units accounting for 
1,965 admissions and a population of 2·14 million in 2013/14 (1,817 admissions, 2·17 million 
population in 2013/14).  
 
Figure 2 presents the change in paediatric epilepsy admission rates over time by change in performance 
in each audit indicator (worse, same, and better groups). In the 16 units where access to an ESN 
deteriorated, the standardised ratio of epilepsy admissions increased by a mean of 0·21 (95% CI 0·01-
0·42, p=0·043) over the study period. This represents a mean increase of 21% of the expected number 
of admissions for each unit (taking into account the size and characteristics of the population served). 
No significant differences in standardised admission rates were seen among units with the same or 
better access to ESNs or for any of the subgroups relating to accessing paediatric expertise or paediatric 
neurologists. Full details of the changes in audit performance and admission rates over time within 
each group are presented in Table 4.  
 
DISCUSSION 
 
In this national, longitudinal study, 7% of adolescents with epilepsy who were admitted to hospital died 
within the study period (median 4·5 years, range 3.0-6.0). We found a clinically and statistically 
significant association between being managed in a paediatric epilepsy unit with good links to a 
paediatric neurologist and lower mortality risk. In planned subgroup analyses, the link between better 
audit performance and lower mortality was largely explained by fewer post-transition deaths; no 
significant association was seen between audit performance and pre-transition deaths.  
Units where involvement of an Epilepsy Specialist Nurse (ESN) deteriorated over time experienced a 
significant increase in standardised epilepsy admissions over the same period. However, units where 
ESN access improved over time did not experience any matching decrease in epilepsy admissions.  
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Strengths of this study include the use of prospectively collected, national datasets, which are 
sufficiently large to allow analysis of the relationship between service-level performance and epilepsy 
outcomes. Assessing a new patient who meets criteria for involvement of a PN is a relatively rare event 
for many small or medium size units (46/101 units had one or zero such patients within the data 
collection period for Round 1 of the Epilepsy12 audit). Large studies using routinely-collected data are 
therefore likely to be the only feasible way to address these research questions. Data completeness was 
high in all datasets: Epilepsy12 covers over 95% of paediatric epilepsy units in England, while HES 
covers 98-99% of paediatric hospital admissions, and the ONS records all registered deaths in England. 
While 23/101 units were excluded from the admission analyses due to linkage difficulties, this was 
largely due to hospital mergers or reconfigurations during the study period. As with the exclusion of 
patients whose care is primarily manged by a tertiary specialist centre (9 units), we believe this is 
unlikely to introduce significant bias to our findings. However, our findings are clearly less 
generalisable to patients with specific diagnoses (e.g. absence epilepsies) where unplanned hospital 
admission is rare or to patients who have not been referred to a paediatric epilepsy unit. 
 
As with all observational studies, there is a risk of confounding. For the admission analyses, this risk is 
minimised, as we investigated the association between unit-level changes in performance and unit-level 
changes in admission rates. For the mortality analyses, we used a longitudinal study design, and we 
were able to adjust for several potential confounders, including population characteristics, size/nature 
of the service and measures of hospital activity. However, the analyses are limited by lack of individual 
level data, and hospital activity is clearly an imperfect proxy for disease severity or prognosis. All other 
things being equal, units seeing sicker patients might be expected to have greater involvement of a PN 
and to have higher mortality rates than other units. It is therefore possible that our findings 
underestimate the true association between greater involvement of a PN and lower mortality risk.  
 
Policy implications 
Recent policy initiatives and financial incentives to improve the quality of paediatric epilepsy care in 
the NHS have focused on ensuring that all CYP with epilepsy are seen by a paediatrician with epilepsy 
expertise and an Epilepsy Specialist Nurse (ESN) (reported by 87% and 59% of patients respectively in 
the most recent Epilepsy12 audit).(6) Our findings suggest that the additional involvement of a 
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Paediatric Neurologist (PN) in the care of complex patients (reported by 57%) may be of at least equal 
importance.  
 
However, our study has limited ability to investigate which are the ‘key ingredients’ of PN 
involvement which might reduce long-term mortality. Compared to paediatricians working in local 
paediatric epilepsy units, PNs benefit from extended neurology training, they often have longer 
consultations with patients, and typically have better access to investigations and multi-disciplinary 
support. The exact mechanisms through which PN care may mitigates key risk factors such as poor 
adherence to medication, poor sleep hygiene, mental health problems, and risk behaviours, including 
alcohol use(2, 3) are therefore unclear. However, our data suggest that better preparation and support 
for young people to engage with adult neurology teams after transition may be one important 
mechanism, consistent with previous literature suggesting a protective effect of high-quality 
developmentally appropriate services during adolescence on future health outcomes.(20-22).  
 
Our findings regarding the association between ESN involvement and admissions and mortality rates 
also deserve further investigation. Whereas one previous study reported that increased access to an 
ESN was associated with a large drop in admission rates,(23) we found no such relationship in our 
study. However, we did find that units which reported reduced ESN access experienced an increase in 
admissions over the study period. The lack of a consistent relationship between ESN access and 
epilepsy admission may reflect changes in the skills or role of ESNs since their presence was 
incentivised in the Best Practice Tariff (BPT). It may also reflect limitations of the relatively crude 
performance measure in Epilepsy12, the limited follow up period, and the narrow focus on death and 
hospital admission as outcomes. Future studies would benefit from including a wider range of patient 
important outcomes for CYP with epilepsy, for example, educational, occupational, and mental health 
measures.  
 
While our findings cannot be directly applied to other countries with different health systems, the 
principle that high quality paediatric care can reduce epilepsy-related mortality is highly relevant 
globally. Across the world, children with epilepsy face many challenges, including stigma, out-dated 
beliefs about the causes and effective treatment of epilepsy, and financial barriers to accessing high 
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quality care.(1) Our findings may also have implications for improving adult outcomes of other long-
term conditions which present in childhood and adolescence. It is well-recognised that complication 
rates increase in the immediate period following transition for diabetes, renal disease, and many other 
long-term conditions.(24-27) Advocates for adolescent health have long argued that adolescence is a 
second critical window of development when the foundations of adult health are laid down, and when 
access to high quality services may have long-term benefits.(21, 28) Our findings support this 
hypothesis, providing evidence that access to higher quality, more developmentally appropriate care in 
early and mid-adolescence could play an important role in  improving adult health outcomes for many 
long-term conditions.  
 
Conclusion 
Through linkage of large, prospectively-collected, national datasets, this study shows that quality of 
paediatric epilepsy care (specifically the involvement of a Paediatric Neurologist in the management of 
complex cases) is an important predictor of mortality risk in the period following transition to an adult 
service. We also report evidence that lack of access to an Epilepsy Specialist Nurse is linked to higher 
admission rates for children with epilepsy. Further work with individual level data linkage and a wider 
range of outcome measures is needed to inform future design of services and improve epilepsy 
outcomes.  
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Table 1. Key definitions and background information 
 
 
 
Epilepsy12 terms  
 
Paediatric epilepsy unit All children and young people in England with diagnosed or suspected epilepsy should be under 
the care of a paediatric epilepsy unit. This is a local unit or service - often part of a general or 
community paediatric team - and can access specialist support from their regional paediatric 
neurology service.  
Epilepsy12 national 
clinical audit 
The Epilepsy12 audit collects data on patients presenting to each paediatric epilepsy unit in order 
‘to measure and improve the quality of care for children and young people (CYP) with seizures 
and epilepsies’ 
 
Inclusion critera 
• First EEG during 12-month period during defined period prior to ‘census day’ 
• The child had a first paediatric assessment for the paroxysmal episode or episodes during 
the defined 6-month time prior to census day 
• Child is older than 1 month and younger than 16 years at first paediatric assessment 
• The EEG was prompted by the patient having one or more afebrile paroxysmal episodes 
 
Exclusion criteria include diagnosis of febrile or acute symptomatic seizures or that first 
assessment/first year of care were provided across more than one unit. 
Hospital Trust A healthcare provider organisation, which may operate across many geographical sites. Some 
large Trusts have more than one paediatric epilepsy unit.  
Paediatrician with 
expertise in epilepsy. 
A paediatric consultant having:  training and continuing education in epilepsies AND peer 
review of practice AND regular audit of diagnosis. It is recommended that a paediatrician with 
epilepsy expertise should be involved in the care of all CYP with epilepsy. Epilepsy12 reports 
the proportion of patients within each unit for whom this happens in practice.  
 
Epilepsy Specialist 
Nurse (ESN) 
A children’s nurse with a defined role and specific qualification and/or training in children’s 
epilepsies. It is recommended that ESNs should be involved in the care of all CYP with epilepsy. 
Epilepsy12 reports the proportion of patients within each unit for whom this happens in practice.  
Paediatric neurologist A consultant with specialist training in paediatric neurology. Paediatric neurologists are typically 
based at tertiary (specialist) centres, which are excluded from this study. However, it is 
recommended that local paediatric epilepsy units should involve paediatric neurologists in the 
care of all CYP with epilepsy who present before their 2nd birthday OR who are prescribed 3 or 
more maintenance anti-epilepsy drugs within the first 12 months of care. This involvement could 
be through referral to the specialist centre or through a paediatric neurology outreach clinic. 
Epilepsy12 reports the proportion of eligible patients in each unit for whom this happens in 
practice.  
 
Key outcomes and covariates 
 
Pre-transition deaths Deaths occurring while under care of a paediatric unit OR within 6 months of last planned 
paediatric appointment 
Post-transition deaths Deaths occurring while under the care of adult services OR at least 6 months from last planned 
paediatric appointment  
Successful transition Attending an adult clinic within 6 months of the last paediatric appointment AND then attending 
at least two further planned appointments within the subsequent 2 years. 
Index of Multiple 
Deprivation (IMD) 
quintile 
A measure of socio-economic deprivation (socio-economic position), derived from the patients’ 
postcode.  
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Table 2. Unit-level association between performance on involving a paediatric neurologist in the 
Epilepsy12 national clinical audit and mortality  
 
 
Panel A: audit performance entered as continuous variable (0-100% of eligible patients 
saw a paediatric neurologist) 
 
          
 
POST TRANSITION DEATHS 
 
ALL DEATHS 
          
 
Beta 95% CI P 
 
Beta 95% CI P 
          
Unadjusted -0.040 -0.080 0.000 0.049 
 
-0.030 -0.079 0.019 0.228 
          
Adjusted for 
population, unit and 
severity characteristics 
-0.057 -0.108 -0.006 0.028 
 
-0.064 -0.127 -0.001 0.046 
          
Additionally adjusted 
for transition outcomes 
-0.048 -0.100 0.004 0.067 
 
-0.057 -0.119 0.004 0.067 
          
 
 
Panel B: audit performance entered as a dichotomised variable (0-99 vs. 100% of eligible 
patients saw a paediatric neurologist)           
 
POST TRANSITION DEATHS 
 
ALL DEATHS 
          
 
Beta 95% CI 
 
P 
 
Beta 95% CI P 
          
Unadjusted -0.034 -0.063 -0.006 0.02 
 
-0.027 -0.063 0.009 0.14 
          
Adjusted for 
population, unit and 
severity characteristics 
-0.046 -0.080 -0.012 0.01 
 
-0.046 -0.089 -0.003 0.038 
          
Additionally adjusted 
for transition outcomes 
-0.037 -0.074 0.000 0.049 
 
-0.038 -0.083 0.007 0.095 
 
 
 
Notes 
A beta coefficient of -0.040 indicates an absolute reduction of 4.0% (95% CI 0.0-8.0%) in total mortality risk between units 
where all versus no eligible patients were seen by a paediatric neurologist. (i.e. 4.0 fewer deaths per hundred patients). Variables 
included in each model are listed below.   
Population characteristics: Mean Index of Multiple Deprivation (IMD) quintile; Ethnicity (defined as proportion of patients who 
were White, Mixed ethnicity, Asian, Black, Other ethnicity.  
Unit characteristics: Number of patients; mean transition age; hosts paediatric neurology clinic; young people clinic; adult 
epilepsy specialist nurse.  
Pre transition healthcare activity: Mean number of inpatient care episodes; Mean number of outpatient visits; Mean number of 
contacts with mental health services; Mean number of unplanned care episodes. Post transition hospital activity: Mean number of 
inpatient care episodes; Mean number of contacts with mental health services; Mean number of unplanned care episodes.  
Transition outcomes: Proportion of patients with any adult outpatient visits; Proportion of patients with adult outpatient visit 
within 12 months of last paediatric appointment; Proportion of patients with adult outpatient visit within 6 months of last 
paediatric appointment; Proportion of patients with adult outpatient visit within 6 months of last paediatric appointment and at 
least two further visits within next 24 months.   
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Table 3. Proportion of epilepsy patients who died, by unit performance on Epilepsy12 measures 
 
 
 
 
 
 
Epilepsy12 
performance 
N 
patients 
N 
units 
Deaths pre 
transition 
Deaths post 
transition 
Total deaths 
 
    N % N % N % 
Proportion 
seen by 
paediatrician 
with expertise 
Good (100%) 263 18 6 2·3% 14 5·3% 20 7·6% 
Moderate (50- 99%) 1017 48 28 2·8% 51 5·0% 79 7·8% 
Poor (0-49%) 515 33 12 2·3% 23 4·5% 35 6·8% 
 Total 1795 99 46 2.6% 88 4.9% 134 7.5% 
          
Proportion 
seen by 
Epilepsy 
Specialist 
Nurse (ESN) 
Good (100%) 1104 64 28 2·5% 51 4·6% 79 7·2% 
Moderate (50-99%) 638 30 18 2·8% 33 5·2% 51 8·0% 
Poor (0-49%) 53 5 0 0·0% 4 7·5% 4 7·5% 
 Total 1795 99 46 2.6% 88 4.9% 134 7.5% 
          
Proportion of 
eligible 
patients seen 
by paediatric 
neurologist 
 
Good (100%) 231 12 5 2·2% 5 2·2% 10 4·3% 
Moderate (50-99%) 549 27 12 2·2% 28 5·1% 40 7·3% 
Poor (0-49%) 384 16 8 2·1% 21 5·5% 29 7·6% 
 Total 1164 55 25 2.1% 54 4.6% 79 6.8% 
 
 
Notes. Numbers for the PN analyses differ as 44 units had sufficient patients to be included in the in the paediatrician with 
expertise and ESN analyses but too few eligible patients for the PN analyses (see Figure 1).  
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Table 4. Changes in epilepsy admission rates 2011/12 - 2013/14, by change in performance 
between Rounds 1 & 2 of the Epilepsy12 national clinical audit.  
 
 
 
Change in Epilepsy12 performance 
   
Change in standardised 
admission ratio 
  Median Minimum Maximum N  Mean 95% CI 
Paediatrician with 
epilepsy expertise 
 
 
Worse -20.0% -100.0% -6.5% 15  0.10 -0.06 0.26 
Same 0.0% 0.0% 0.0% 19  0.04 -0.11 0.20 
Better 16.7% 3.4% 100.0% 40  0.06 -0.05 0.18 
          
Epilepsy Specialist 
Nurse 
 
 
 
Worse -14.3% -83.3% -2.0% 16  0.21 0.01 0.42 
Same 0.0% 0.0% 0.0% 19  -0.07 -0.20 0.06 
Better 25.0% 2.4% 100.0% 39  0.06 -0.04 0.17 
          
Paediatric 
neurologist 
 
 
 
Worse -42.9% -100.0% -16.7% 14  -0.04 -0.27 0.18 
Same 0.0% 0.0% 0.0% 2  0.33 -0.28 0.95 
Better 30.0% 6.7% 50.0% 9  0.27 -0.06 0.61 
 
 
 
Notes 
This table presents the number of units reporting worse, same, and better performance for each indicator in Round 2 of the 
Epilepsy12 audit, compared to Round 1. The minimum, maximum and median percentage point increases in performance within 
each group are shown, as well as the mean difference in observed:expected admission ratio. For each unit, the difference in 
standardised admission ratios reflects the trajectory of paediatric epilepsy admission in each unit, relative to the trajectory that 
would be expected given national trends over the study period and any changes in the size and/or composition of the catchment 
population. Weighted mean differences for all units in each category are presented.  
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Figure 1. Flow chart of linking process between Epilepsy12, death registration and hospital 
activity data. 
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Figure 2. Change in unit-level epilepsy admission rates for patients 0-18 years in England 
between 2011/12 and 2013/14 by change in performance in Epilepsy 12 indicators over the same 
period. 
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APPENDIX 
 
 
Appendix. Table A. Characteristics of population, service, and activity in units that do and do 
not meet recommended standards for involvement of a Paediatric Neurologist. 
 
 
 
 
Recommendations not fully met 
 (N=43 units) 
 
Recommendations fully met 
 (N=12 units) 
 
 
Mean 
value 95% CI 
Mean 
value 95% CI p 
Population characteristics        
% White 84.9% 79.4% 90.4% 85.2% 71.6% 98.7% 0.98 
% most deprived 27.8% 22.8% 32.9% 26.7% 20.4% 33.1% 0.829 
% least deprived 15.5% 11.3% 19.7% 15.9% 4.5% 27.2% 0.936 
 
Unit size and characteristics        
Mean number patients 21.7 17.4 26.0 19.3 13.5 25.0 0.586 
Mean transition age (years) 17.9 17.8 18.0 17.9 17.7 18.1 1 
 
Whole Time Equivalent general 
paediatric consultants 12.7 11.4 14.1 11.4 8.9 13.9 0.354 
 
Host paediatric neurology clinic* 83.7% 72.3% 95.1% 91.7% 75.0% 100% 0.67 
Young people's clinic* 27.9% 12.5% 43.3% 0.0%   0.05 
Adult ESN* 90.7% 73.3% 108.1% 50.0% 11.0% 90.2% 0.4% 
 
Mean number of pre-transition care episodes     
In patient episodes 5.5 3.8 7.2 7.3 1.5 13.1 0.41 
Total unplanned care episodes 5.2 4.5 5.8 5.3 4.0 6.7 0.825 
Outpatient episodes 15.0 13.0 17.1 14.2 11.7 16.7 0.667 
Mental health care episodes 0.04 0.02 0.05 0.05 0.01 0.08 0.684 
 
Mean number of post-transition care episodes     
Inpatient episodes 1.8 1.4 2.3 2.3 1.2 3.3 0.4 
Total unplanned care episodes  2.0 1.6 2.5 2.8 1.5 4.2 0.407 
Mental health care episodes  0.7 0.3 1.1 0.7 0.2 1.1 0.939 
 
Transition measures        
% any planned care episodes post 
transition 76.7% 72.8% 80.6% 88.6% 81.5% 95.6% 0.006 
% seen within 12 months post transition 55.2% 49.9% 60.5% 68.9% 60.6% 77.1% 0.015 
% seen within 6 months transition 40.4% 34.3% 46.4% 57.0% 50.1% 63.9% 0.011 
% Successful transition 32.8% 27.5% 38.1% 45.9% 40.2% 51.7% 0.019 
 
 
 
Notes. Chi-squared tests were used for comparisons of dichotomised outcomes (marked with *); t tests 
were used for all the remaining comparisons. Successful transition was defined as having a recorded 
adult outpatient visit within 6 months of last paediatric appointment and at least two further visits 
within next 24 months 
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Appendix Figure 1. Scatterplot of paediatric neurologist involvement and post-transition 
mortality 
 
 
 
